Table 1.
Effect of Ellagic acid treatment on serum creatinine, urea, uric acid and albumin on lead acetate induced nephrototoxicity.
| Treatment | Blood serum level (mg/dl) |
|||
|---|---|---|---|---|
| Urea | Uric acid | Creatinine | Albumin | |
| Negative control | 31.87 ± 0.89 | 2.56 ± 0.09 | 0.65 ± 0.02 | 3.86 ± 0.90 |
| Positive control | 68.08 ± 1.93∗∗∗ | 7.30 ± 0.10∗∗∗ | 2.90 ± 0.08∗∗∗ | 2.80 ± 0.01∗∗∗ |
| EA 50 | 42.72 ± 1.17### | 3.58 ± 0.14### | 1.09 ± 0.03### | 3.60 ± 0.09### |
| EA 25 | 49.86 ± 1.29### | 4.44 ± 0.11### | 1.40 ± 0.05### | 3.30 ± 0.04### |
All values are mean ± SEM, n = 8, ∗∗∗P < 0.001 when compared to Negative control; ###P < 0.001 compared to Positive control group. EA 50: Ellagic acid (50 mg/kg) EA 25: Ellagic acid (25 mg/kg).